Oncology

Breast cancer

Breast cancer

One in 8 women in the EU will develop breast cancer before the age of 85. This disease is associated with a great economic cost. In fact, in 2010 it was estimated at more than €15 billion in Europe. About 46% of the breast cancer cost is spent on treatments and drugs1 that are selected by general guidelines and may not be efficient for a specific patient.

1 in 8

women will develope it

bigmedilytics-cost-health-service

>€ 15 billion cost

Drugs selected by general

guidelines

Led by IBM, this pilot supports precision medicine to improve accuracy in diagnosis and propose treatments that are more targeted, less toxic and therefore better tolerated.

Why a big data approach is needed

Prediction by big data analytics can support the physicians on their decision for the personalized optimal treatment for the patient.

Leader
IBM
Participants
Institut Curie
VTT

Publications

Multimodal Prediction of Breast Cancer Relapse Prior to Neoadjuvant Chemotherapy Treatment

10/02/2021

Rabinovici-Cohen S., Abutbul A., Fernández X.M., Hijano Cubelos O., Perek S., Tlusty T. (2020) Multimodal Prediction of Breast Cancer Relapse Prior to Neoadjuvant Chemotherapy Treatment. In: Rekik I., Adeli E., Park S.H., Valdés Hernández M..C. (eds) Predictive Intelligence in Medicine. PRIME 2020. Lecture Notes in Computer Science, vol 12329. Springer, Cham. https://doi.org/10.1007/978-3-030-59354-4_18

Radiomics for predicting response to neoadjuvant chemotherapy treatment in breast cancer

15/04/2020

Simona Rabinovici-Cohen, Tal Tlusty, Ami Abutbul, Kari Antila, Xosé Fernandez, Beatriz Grandal Rejo, Efrat Hexter, Oliver Hijano Cubelos, Abed Khateeb, Juha Pajula, and Shaked Perek “Radiomics for predicting response to neoadjuvant chemotherapy treatment in breast cancer”, Proc. SPIE 11318, Medical Imaging 2020: Imaging Informatics for Healthcare, Research, and Applications, 113181B (2 March 2020); https://doi.org/10.1117/12.2551374

Pillot 8: Breast cancer

04/10/2019

Poster at the BigMedilytics event: “Big Data: Fueling the transformation of Europe’s Healthcare Sector”. September 4-5, 2019, Valencia, Spain


1 Source: Capri S., Russo A.: Cost of breast cancer based on real-world data: a cancer registry study in Italy, BMC health Services Research, 17(1):84, 2017.